The Minister of Health promulgated regulations establishing a Transparent Pricing System for Medicines under s 22G of the Medicines and Related Substances Act 101 of 1965. The regulations fixed a ‘single exit price’ for manufacturers, prohibited discounts, and prescribed capped dispensing fees for pharmacists. The Pharmaceutical Society of South Africa and New Clicks SA (Pty) Ltd, representing pharmacy interests, brought urgent review applications in the Cape High Court challenging the validity and legality of the regulations. The High Court dismissed the reviews. The applicants immediately sought leave to appeal, but the High Court delayed delivering its ruling on leave. Before that ruling was issued, the applicants approached the Supreme Court of Appeal (SCA) for leave to appeal, raising procedural and jurisdictional objections from the respondents, including urgency, separation of issues, and whether the SCA had jurisdiction in the absence of a prior ruling by the High Court.